AlphaCore Capital’s Globus Medical GMED Stock Holding History

AlphaCore Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$614K	Buy	+8,195	New	+$649K	0.01%	709

Other funds holding GMED

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

AlphaCore Capital's GMED Position: Q3 2026 in Review

AlphaCore Capital opened a new position in Globus Medical (GMED) in Q3 2026: 8,195 shares worth $614K. The stake represents 0.01% of the portfolio and ranks #709 among its holdings.

324 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

AlphaCore Capital held 8,195 shares of Globus Medical worth $614K as of Q3 2026.
Globus Medical was a new AlphaCore Capital position in Q3 2026.
Globus Medical made up 0.01% of AlphaCore Capital's portfolio in Q3 2026, its #709 holding.
324 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.